AI-Powered Drug Discovery Market Size to Reach USD 9.2 Billion by 2035 | North America & Asia-Pacific Drive Pharmaceutical AI Innovation
Market Overview According to MarketGenics , the global AI-Powered Drug Discovery Market is estimated to be valued at USD 1.0 billion in 2025 and is projected to reach USD 9.2 billion by 2035 , expanding at a CAGR of 24.6% during the forecast period. The market is experiencing remarkable growth as pharmaceutical and biotechnology companies increasingly adopt artificial intelligence to accelerate drug discovery, optimize clinical development, and reduce research costs. AI technologies such as machine learning, deep learning, natural language processing, and generative AI are transforming the identification of drug targets, molecular design, biomarker discovery, toxicity prediction, and compound screening. The growing demand for precision medicine, increasing R&D investments, and the integration of AI with genomics, proteomics, and real-world data analytics are further driving the adoption of AI-powered drug discovery platforms across the global pharmaceutical industr...